Cargando…

Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders

SIMPLE SUMMARY: Hairy cell leukemia (HCL) is a rare B cell neoplasm that accounts for 2% of B-cell lymphomas. The diagnosis was based on the presence of abnormal lymphoid cells that expressed CD103, CD123, CD25 and CD11c. The aim of this retrospective study was to describe the immunophenotypic profi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maitre, Elsa, Cornet, Edouard, Salaün, Véronique, Kerneves, Pauline, Chèze, Stéphane, Repesse, Yohan, Damaj, Gandhi, Troussard, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870214/ https://www.ncbi.nlm.nih.gov/pubmed/35205796 http://dx.doi.org/10.3390/cancers14041050

Ejemplares similares

Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients
por: Maitre, Elsa, et al.
Publicado: (2022)

Variant form of hairy cell leukemia
por: Wiber, Margaux, et al.
Publicado: (2019)

Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib
por: Paillassa, Jérôme, et al.
Publicado: (2022)

Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders
por: Maitre, Elsa, et al.
Publicado: (2022)

New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes
por: Maitre, Elsa, et al.
Publicado: (2018)

Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up
por: Paillassa, Jerome, et al.
Publicado: (2020)

Protein profiling by reverse phase protein array (RPPA) in classical hairy cell leukemia (HCL) and HCL‐variant
por: Hoff, Fieke W., et al.
Publicado: (2022)

Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy
por: Maitre, Elsa, et al.
Publicado: (2022)

Hairy cell leukemia 2018: Update on diagnosis, risk‐stratification, and treatment
por: Troussard, Xavier, et al.
Publicado: (2017)

Patients with relapsed/refractory hairy‐cell leukemia
por: Paillassa, Jérôme, et al.
Publicado: (2021)

Hairy cell leukaemia with unusual BRAF mutations
por: Maitre, Elsa, et al.
Publicado: (2023)

Hairy Cell Leukemia: Hematological and Immunophenotypic Profile of 13 Patients
por: Bhatti, Vandana, et al.
Publicado: (2023)

Hairy cell leukemia with isolated bone lesions
por: Cailly, Laura, et al.
Publicado: (2023)

Hairy Cell Leukemia (HCL) Presenting As Severe Acute Respiratory Distress Syndrome (ARDS) With Legionella pneumophila: Coincidence or Causation?
por: Holloway, Kayln D, et al.
Publicado: (2023)

Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial
por: Kreitman, Robert J., et al.
Publicado: (2021)

Hairy Cell Leukemia (HCL) Presenting with Joint Swelling: Case Report and Literature Review of a Rare Rheumatological Manifestation of a Hematological Disease
por: Anil, Vishwanath, et al.
Publicado: (2023)

Genomics of Hairy Cell Leukemia
por: Tiacci, Enrico, et al.
Publicado: (2017)

A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia
por: Broccoli, Alessandro, et al.
Publicado: (2022)

BRAF Mutation in Hairy Cell Leukemia
por: Ahmadzadeh, Ahmad, et al.
Publicado: (2014)

Hairy cell leukemia – immunotargets and therapies
por: Basheer, Faisal, et al.
Publicado: (2014)

Skeletal involvement of hairy cell leukemia
por: Durot, Eric, et al.
Publicado: (2018)

Time to Cure Hairy Cell Leukemia
por: Levy, Ilana, et al.
Publicado: (2017)

An Unusual Presentation of Hairy Cell Leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2019)

Skin changes in hairy cell leukemia
por: Robak, Ewa, et al.
Publicado: (2020)

The Biology of Classic Hairy Cell Leukemia
por: Bohn, Jan-Paul, et al.
Publicado: (2021)

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
por: Kreitman, Robert J., et al.
Publicado: (2018)

PB2068: RETROSPECTIVE ANALYSIS OF HAIRY CELL LEUKEMIA (HCL) PATIENTS (PTS) TREATED WITH DIFFERENT MODALITIES AS FIRST LINE: REAL-LIFE EXPERIENCE OVER 20 YEARS IN KUWAIT.
por: Alhuraiji, A., et al.
Publicado: (2022)

Laparoscopic Splenectomy for Hairy Cell Leukemia in Pregnancy
por: Adeniji, Beni Adegoke, et al.
Publicado: (2010)

A Unique Hairy Cell Leukemia Variant
por: Jian, Charles, et al.
Publicado: (2016)

Hairy Cell Leukemia Masquerading as Pancytopenia in Pregnancy
por: Shackleton, Louisa, et al.
Publicado: (2019)

Development of Recombinant Immunotoxins for Hairy Cell Leukemia
por: Kreitman, Robert J., et al.
Publicado: (2020)

Disseminated Histoplasmosis with Concurrent Hairy Cell Leukemia
por: Khan, Abdul Moiz, et al.
Publicado: (2020)

Hairy Cell Leukemia: Where Are We in 2023?
por: Mendez-Hernandez, Andres, et al.
Publicado: (2023)

Simultaneous Presentation of Hairy Cell Leukemia and Acute Lymphoblastic Leukemia
por: Li, Mingyong, et al.
Publicado: (2021)

Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
por: Grever, Michael, et al.
Publicado: (2021)

Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia
por: Cornet, Edouard, et al.
Publicado: (2014)

Hairy Cell Leukemia Treatment: Where We Are Now?
por: Krstevska, Svetlana, et al.
Publicado: (2011)

Two Cases of Q-Fever in Hairy Cell Leukemia
por: Ammatuna, Emanuele, et al.
Publicado: (2014)

Current and emerging treatment options for hairy cell leukemia
por: López-Rubio, Montserrat, et al.
Publicado: (2015)

Hairy cell leukemia variant: the importance of differential diagnosis
por: Rudolf-Oliveira, Renata Cristina Messores, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_12fa9e9rkejhu9dr834k93ut80